These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9614372)

  • 1. The development of haematopathology laboratories: a possible model for other pathology services.
    Jack AS; Morgan GJ
    J Pathol; 1998 Mar; 184(3):231-3. PubMed ID: 9614372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organisation of neoplastic haematopathology services: a UK perspective.
    Jack A
    Pathology; 2005 Dec; 37(6):479-92. PubMed ID: 16373228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specialist integrated haematological malignancy diagnostic services: an Activity Based Cost (ABC) analysis of a networked laboratory service model.
    Dalley C; Basarir H; Wright JG; Fernando M; Pearson D; Ward SE; Thokula P; Krishnankutty A; Wilson G; Dalton A; Talley P; Barnett D; Hughes D; Porter NR; Reilly JT; Snowden JA
    J Clin Pathol; 2015 Apr; 68(4):292-300. PubMed ID: 25631214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haematological malignancies: the rationale for integrated haematopathology services, key elements of organization and wider contribution to patient care.
    Ireland R
    Histopathology; 2011 Jan; 58(1):145-54. PubMed ID: 21261689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The development of integrated haematopathology laboratories: a new approach to the diagnosis of leukaemia and lymphoma.
    Richards SJ; Jack AS
    Clin Lab Haematol; 2003 Dec; 25(6):337-42. PubMed ID: 14641135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The Haemolymphopathology Italian Group (H.I.G.): an essential resource for the new technical and organization problems troubling modern haemolymphopathology diagnostics].
    Paulli M; Artusi T; Baroni CD; Carbone A; Coggi G; Di Lollo S; Facchetti F; Falini B; Franco V; Gambacorta M; La Rocca VM; Leoncini L; Magrini U; Maiorana A; Menestrina F; Novero D; Palestro G; Pescarmona E; Santucci M; Stracca Pansa V; Truini M; Pileri S
    Pathologica; 2006 Feb; 98(1):37-40. PubMed ID: 16789684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular genetic analysis of haematological malignancies: I. Acute leukaemias and myeloproliferative disorders.
    Bench AJ; Erber WN; Scott MA
    Clin Lab Haematol; 2005 Jun; 27(3):148-71. PubMed ID: 15938721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perspectives of gene expression profiling for diagnosis and therapy in haematological malignancies.
    Bacher U; Kohlmann A; Haferlach T
    Brief Funct Genomic Proteomic; 2009 May; 8(3):184-93. PubMed ID: 19474126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular hematology. Qualitative to quantitative techniques.
    Khalil SH
    Saudi Med J; 2005 Oct; 26(10):1516-22. PubMed ID: 16228048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Flow cytometry: application for the diagnosis and the follow-up of hematological malignancies].
    Drénou B; Fardel O; Fauchet R; Amiot L
    Ann Biol Clin (Paris); 2002; 60(6):663-72. PubMed ID: 12446230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular diagnosis and new gene engineering in hematological malignancies].
    Funato T; Fujiwara J; Fujimaki S; Kaku M
    Rinsho Byori; 2000 Oct; 48(10):887-91. PubMed ID: 11215098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frozen sections in hematopathology.
    Solomon AC; Kossev PM
    Semin Diagn Pathol; 2002 Nov; 19(4):255-62. PubMed ID: 12469792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Morphology and immunophenotyping in hematological malignancies].
    Kawai Y; Shimizu N; Ujiie M; Takeshita E; Todoroki T; Mitsuhashi T; Watanabe K
    Rinsho Byori; 2000 Aug; 48(8):694-701. PubMed ID: 11064591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Scottish molecular genetics consortium--15 years on.
    Kelly KF
    Health Bull (Edinb); 2002 Jan; 60(1):83-90. PubMed ID: 12664773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Making the most of your hematology proficiency surveys.
    Gheen DL
    MLO Med Lab Obs; 1993 Dec; 25(12):30-1. PubMed ID: 10145943
    [No Abstract]   [Full Text] [Related]  

  • 16. Modern molecular diagnostics and the management of haematological malignancies.
    Morgan GJ; Pratt G
    Clin Lab Haematol; 1998 Jun; 20(3):135-41. PubMed ID: 9681227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Pathology Laboratory Act 2007 explained.
    Looi LM
    Malays J Pathol; 2008 Jun; 30(1):1-10. PubMed ID: 19108405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Strategy for diagnosing hematological malignancies--a proposal from hematologists to laboratory medicine].
    Miyazaki Y; Kuriyama K
    Rinsho Byori; 2000 Aug; 48(8):685-8. PubMed ID: 11064589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Optimising therapy in patients with haematological malignancies].
    Dumontet C
    Bull Cancer; 2008 Oct; 95(10):959-62. PubMed ID: 19004726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synoptic tool for reporting of hematological and lymphoid neoplasms based on World Health Organization classification and College of American Pathologists checklist.
    Mohanty SK; Piccoli AL; Devine LJ; Patel AA; William GC; Winters SB; Becich MJ; Parwani AV
    BMC Cancer; 2007 Jul; 7():144. PubMed ID: 17672904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.